Cell-Selective Oligonucleotide STAT3 Inhibitor for Immunotherapy of Human Acute Myeloid Leukemia
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-3-s2-p362
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
BMJ